Designing Medical Devices for Manufacturing Automation and Large-Scale Production

Why Design for Automation (DfA) is Driving Innovation and Efficiency in Product Development

The trending evolution of the medical device industry towards more complex solutions has necessitated a corresponding shift in manufacturing practices, especially as it relates to manufacturing automation. The need for efficiency, scalability and strict compliance with regulatory standards has brought Design for Automation (DfA) to the forefront of product development. 

A strategic approach focused on optimizing design for automated manufacturing processes, DfA reduces manual labor, which in turn lowers production costs and mitigates errors and risks. Additionally, it accelerates time to market – a critical factor in today’s competitive and fast-paced landscape.

Leveraging DfA encourages companies to anticipate potential manufacturing obstacles and devise solutions that are both cost-effective and scalable. By incorporating DfA principles in the early stages of product design, manufacturers can ensure their products are optimized for commercialization and streamline the path to market.

In this article, I focus on how DfA can be utilized for product categories like implantable devices and combination drug devices to drive success. 

Understanding DfA and How It Can Be Used

First, it’s important to understand the primary objective of DfA: to streamline the manufacturing process by designing products in a way that leverages automation. To design a medical device that is optimized for automation, several principles should be considered:

• Project Planning: Comprehensive planning is pivotal. Companies must first assess their current manufacturing process to identify automation opportunities. Then, they can then create a new manufacturing and automation process map and workflows that best match the needs and technology desired.
• Flexible Design to Accommodate Automation: Early designs should be adaptable, allowing for the integration with and use of automated manufacturing processes. This might require modular components or standardizing parts to streamline assembly and testing.
• Error Prevention: Companies should design to minimize the chances of errors during manufacturing, such as incorporating features that guide correct assembly and reduce manual intervention.
• Quality Control: Designs should leverage automated quality control measures. Having features that can easily and quickly be tested by automated systems for quality assurance is vital. 
• Throughput: Finally, designs should promote high throughput, enabling the efficient production of large volumes at an efficient pace.

By adopting DfA principles early, medical device companies can achieve smoother transitions to automated manufacturing to scale and meet market demands.

The Benefits of DfA for the Medical Device Industry

When a product is initially designed with automation in mind, moving from design to FDA approval to manufacturing is simpler. By integrating automation considerations into the early stages of product design, companies can ensure compliance with stringent regulatory standards from the outset. This proactive approach minimizes the likelihood of design-related issues that could lead to costly and time-consuming resubmissions. 

Another benefit of DfA is improved control over the supply chain. DfA embeds automation-friendly features into the initial product design, ultimately facilitating more precise and predictable manufacturing processes. In turn, this improves the management of supply chain activities. Automated systems enable real-time tracking and adjustment of production schedules, leading to better alignment between supply and demand. Additionally, the consistency and reliability of automation reduce the risk of production delays and quality issues, further enhancing overall supply chain stability and leading to more efficient operations. 

DfA is also crucial for a faster path to scalability for medical products. By way of automation, medical devices can be produced more efficiently and with greater consistency, which is important when scaling up from initial production to high-volume manufacturing. Automation-ready designs streamline the transition to large-scale production by ensuring that components and assemblies are compatible with automated systems, reducing the need for modifications. This facilitates quicker ramp-ups in production capacity, allowing companies to meet growing market demands and accelerate time-to-market for new devices. 

DfA not only shortens the time required to achieve manufacturing scalability but also ensures that the scale-up process is efficient, sustainable, predictable and aligned with industry standards.

The Role of DfA for Implantable Medical Devices

Designing for manufacturing automation in the realm of implantable devices, such as pacemakers or drug-eluting stents, introduces unique challenges. These products must adhere to the highest standards of reliability and safety due to their critical impact and role in patient care. To this end, DfA principles come into play in several ways.

Material selection and processing are instrumental for implantable devices, as these factors directly impact functionality, safety and longevity. Choosing materials compatible with automated manufacturing processes while ensuring biocompatibility and durability is a fundamental consideration. Separately, the processing techniques used must ensure that the final product meets strict quality standards to prevent issues such as infection, inflammation or mechanical failure. DfA principles help simplify the assembly process, which can reduce manufacturing complexity, minimize errors and enhance the overall reliability of the device. 

Additionally, testing and verification for implantable medical devices are essential. Automated testing systems can perform rigorous, repeatable testing under simulated physiological conditions to evaluate all components of the device. Automated verification processes can confirm that the device meets all design specifications and regulatory requirements. Effective testing and verification not only validate the device’s design but also improve quality control and reduce the risk of post-implant complications.

DfA Meets Combination Drug-Device Products

Combination drug-device products couple pharmaceuticals with medical devices. Unsurprisingly, the interplay between the two adds complexity to the design and manufacturing process. It also creates an added challenge of having to navigate dual regulatory pathways, as combination products must meet the safety, efficacy and quality standards for both drugs and devices. This often involves coordinating approvals from multiple regulatory bodies. 

Automation serves a function in maintaining the integrity of the drug component while ensuring precise integration with the device part and adherence to nuanced standards and regulatory processes.

Two key considerations are containment (how the device holds the drug and protects it from contamination) and delivery (how the drug is administered to the patient). For drug-device combos such as auto-injectors or drug-eluting stents, precise dosing and controlled delivery is paramount. Effective DfA practices, such as designing mechanisms that are compatible with automated filling systems, can maintain dosage accuracy and product performance, helping to achieve a reliable and user-friendly combination product.

Material compatibility is also an essential factor here. Materials must be selected not only for their mechanical properties and manufacturability but also for their compatibility with the drug substance. Effective DfA entails rigorous testing and validation of material interactions. 

Lastly, assembly and packaging are important. Assembly calls for precise integration of drug and device components, while packaging must protect the product from environmental factors and physical damage. Automation can streamline the assembly of multi-part components and the final packaging, which often requires a sterile environment. Designing products for easy assembly and integration with automated packaging lines can significantly enhance product quality and production scalability.  

A Real-World Example

A world-renowned Fortune 100 company known for adhesives, healthcare solutions and electronics embraced automation in medical device production to cut costs and boost revenue. 

The company needed to improve how it manufactured and scaled clinical products for commercial use and beyond. Time was of the essence – they not only needed to automate and improve complex manufacturing processes, but they also wanted to do so quickly so they could bring their products to market.

So, they partnered with our team. We designed a manufacturing process for automation, utilizing Good Manufacturing Practices (GMPs) to streamline their approach to medical device production. Adhering to these standards ensured consistent quality and safety in every product and reduced the risk of recalls and compliance issues. Our production line process used state-of-the-art technology such as lasers, robots and servos to usher products from the assembly all the way to delivery. Consisting of about eight steps, the streamlined process reduced room for error and increased the speed of production.  

This comprehensive approach to automation allowed the company to deliver high-quality medical devices quickly and at lower costs, helping them remain at the forefront of the medical manufacturing industry. It reduced the time to market by 12-18 months and led to a 65% reduction in expenses. 

Taking the Next Step with DfA

Designing for automation from day one is a strategic move that can offer medical device manufacturers a competitive edge. By considering automation-friendly design elements, such as material selection, component standardization and ease of assembly and testing, companies can expedite the production process, ensure product quality and achieve cost-effectiveness. Whether dealing with implantable devices or complex drug-device combos, the principles of DfA pave the way for successful large-scale manufacturing, taking medical innovations from concept to global markets seamlessly.